GenoMar Genetics announces the opening of a 100% owned subsidiary in Vietnam. The company will serve the Vietnamese tilapia farmers with high quality genetic material as well as to explore opportunities in the wider aquaculture genetics field.
GenoMar Genetics opens subsidiary in Vietnam, signaling Asian expansion Read More
After more than five years of R&D and systematical breeding work, GenoMar introduces new disease resistant products addressing one of the most economically important diseases in Nile tilapia. Repeated laboratory tests and a field trial have demonstrated an increased survivability of approximately 30 percent for the tilapia selected for streptococcosis resistance.
Increased profitability in tilapia farming using streptococcosis resistant fish Read More
Piscicultura Aquabel Ltd, Brazilian largest tilapia fingerling and juvenile producer is becoming AquaGenetics do Brasil Ltd as part of the business restructuring following the acquisition of AquaAmerica in 2Q 2020.
Piscicultura Aquabel becomes AquaGenetics do Brasil Read More
As part of its ongoing investment programme, the GenoMar Genetics Group, which distributes tilapia genetic products under the brands GenoMar, Aquabel and AquaAmerica has announced the building of a new tilapia breeding and genetics center in the state of Tocantins, Brazil.
GenoMar Genetics begins construction of a new Tilapia breeding center Read More
GenoMar Genetics AS, a wholly owned subsidiary of EW Group GmbH, has announced the signing of an agreement for the acquisition of the genetics and distribution assets of AquaAmerica / AquaPorto, an independent Brazilian tilapia breeding and distribution company based in Minas Gerais, Brazil.
GenoMar acquires AquaAmerica and AquaPorto Read More
